176 related articles for article (PubMed ID: 23639297)
1. ELISA for determination of total coagulation factor XII concentration in human plasma.
Madsen DE; Sidelmann JJ; Overgaard K; Koch C; Gram JB
J Immunol Methods; 2013 Aug; 394(1-2):32-9. PubMed ID: 23639297
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor.
Esnouf MP; Burgess AI; Dodds AW; Sarphie AF; Miller GJ
Thromb Haemost; 2000 Jun; 83(6):874-81. PubMed ID: 10896241
[TBL] [Abstract][Full Text] [Related]
3. A new enzyme-linked immunosorbent assay recognizing both rat and human activated coagulation Factor XII (FXIIa).
Papageorgiou PC; Yeo EL; Backx PH; Floras JS
J Immunol Methods; 2012 Feb; 376(1-2):132-8. PubMed ID: 22251663
[TBL] [Abstract][Full Text] [Related]
4. [Preliminary study on the effects of coagulation factor XII on fibrinolysis].
Hu Y; Wang H; Jiao J; Wang Y; Yu W; Ling X
Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):466-8. PubMed ID: 11877020
[TBL] [Abstract][Full Text] [Related]
5. A nanobody-based method for tracking factor XII activation in plasma.
de Maat S; van Dooremalen S; de Groot PG; Maas C
Thromb Haemost; 2013 Sep; 110(3):458-68. PubMed ID: 23349032
[TBL] [Abstract][Full Text] [Related]
6. Contact activation-induced complex formation between complement factor H and coagulation factor XIIa.
Thangaraj SS; Christiansen SH; Graversen JH; Sidelmann JJ; Hansen SWK; Bygum A; Gram JB; Palarasah Y
J Thromb Haemost; 2020 Apr; 18(4):876-884. PubMed ID: 31984663
[TBL] [Abstract][Full Text] [Related]
7. Factor XII in coagulation, inflammation and beyond.
Didiasova M; Wujak L; Schaefer L; Wygrecka M
Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759
[TBL] [Abstract][Full Text] [Related]
8. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
Mitropoulos KA
Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
Schousboe I
Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
[TBL] [Abstract][Full Text] [Related]
10. Validated detection of anti-GD2 antibody ch14.18/CHO in serum of neuroblastoma patients using anti-idiotype antibody ganglidiomab.
Siebert N; Seidel D; Eger C; Brackrock D; Reker D; Schmidt M; Lode HN
J Immunol Methods; 2013 Dec; 398-399():51-9. PubMed ID: 24055592
[TBL] [Abstract][Full Text] [Related]
11. Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII.
Jones DW; Gallimore MJ; MacKie IJ; Harris SL; Winter M
Br J Haematol; 2000 Sep; 110(3):721-6. PubMed ID: 10997986
[TBL] [Abstract][Full Text] [Related]
12. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma.
Johne J; Blume C; Benz PM; Pozgajová M; Ullrich M; Schuh K; Nieswandt B; Walter U; Renné T
Biol Chem; 2006 Feb; 387(2):173-8. PubMed ID: 16497149
[TBL] [Abstract][Full Text] [Related]
13. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
Schousboe I; Nystrøm BT; Hansen GH
FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
[TBL] [Abstract][Full Text] [Related]
14. Factor XII activation markers do not reflect FXII dependence of thrombin generation induced by polyvinylchloride.
Frank RD; Mueller U; Lanzmich R; Floege J
J Mater Sci Mater Med; 2013 Nov; 24(11):2561-6. PubMed ID: 23864336
[TBL] [Abstract][Full Text] [Related]
15. Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus.
Bertolaccini ML; Mepani K; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2007 Apr; 66(4):533-6. PubMed ID: 17020907
[TBL] [Abstract][Full Text] [Related]
16. Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity.
Iijima K; Arakawa Y; Sugahara Y; Matsushita M; Moriguchi Y; Shimohiro H; Nakagawa M
Thromb Haemost; 2011 Mar; 105(3):473-8. PubMed ID: 21264442
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
Wuillemin WA; Furlan M; Stricker H; Lämmle B
Thromb Haemost; 1992 Feb; 67(2):219-25. PubMed ID: 1621242
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of bradykinin are suppressed in factor XII-deficient mice.
Iwaki T; Castellino FJ
Thromb Haemost; 2006 Jun; 95(6):1003-10. PubMed ID: 16732380
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
Bork K; Kleist R; Hardt J; Witzke G
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
[TBL] [Abstract][Full Text] [Related]
20. Binding of activated Factor XII to endothelial cells affects its inactivation by the C1-esterase inhibitor.
Schousboe I
Eur J Biochem; 2003 Jan; 270(1):111-8. PubMed ID: 12492481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
